Sheel Biotech H1 FY27 Results: Net Profit Surges to Rs 338.54 Lakhs
Sheel Biotech Ltd 路 Outcome 路 14 Nov 2026, 12:14 am
Sheel Biotech H1 FY27 Results: Net Profit Surges to Rs 338.54 Lakhs Sheel Biotech reported a strong H1 ended 30th Sep'26, with revenue from operations surging 131.39% YoY to Rs 5,055.63 lakhs from Rs 2,184.91 lakhs. Profit before tax rose sharply to Rs 412.63 lakhs against Rs 25.11 lakhs in the previous year. Net profit stood at Rs 338.54 lakhs versus Rs 18.85 lakhs in H1 ended 30th Sep'25, driving basic and diluted EPS up to Rs 1.66 from Rs 0.13. Total assets reached Rs 16,979.13 lakhs, while cash and equivalents closed at Rs 21.06 lakhs.
Original exchange filing (PDF)
More announcements from Sheel Biotech Ltd
- Sheel Biotech Limited has informed the Exchange regarding 'Investor Presentation'. 路 17 Nov 2026
- Sheel Biotech Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 13 Nov 2026
- Monitoring Agency Report for the Half year ended on 30th September, 2026. 路 13 Nov 2026
- SHEEL BIOTECH LIMITED has informed the Exchange about Board Meeting to be held on 13-Nov-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and Other business. 路 13 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 and other business matters 路 13 Nov 2026
- Sheel Biotech Limited has informed the Exchange about receipt of Award of Work having contract value of Rs. 1.72 Crore from Sher-e-Kashmir University of Agricultural Sciences and Technology of Jammu (SKUAST-Jammu) for blueberry production. 路 30 Oct 2026
- Statement of Investor Complaints under Regulation 13(3) of Securities and Exchange Board of India (LODR), 2015 for the quarter ended 30th Sept, 2026. 路 14 Oct 2026
- Sheel Biotech Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q2 FY 2026 路 13 Oct 2026
